QuidelOrtho (QDEL) Short-term Investments (2022 - 2023)
QuidelOrtho (QDEL) reported Short-term Investments of $48.4 million for Q4 2023, down 7.1% on a YoY basis from $52.1 million in Q4 2022, and up 10.25% sequentially from $43.9 million in Q4 2023.
QuidelOrtho (QDEL) Short-term Investments (2022 - 2023) Analysis & Trends
QuidelOrtho (QDEL) has 2 years of Short-term Investments data on file, last reported at $48.4 million in Q4 2023.
- For the quarter ending Q4 2023, Short-term Investments fell 7.1% year-over-year to $48.4 million; the trailing twelve-month figure through Dec 2023 stood at $48.4 million (down 7.1% YoY), and the FY2023 full-year result was $48.4 million, down 7.1% from the prior year.
- Short-term Investments improved to $48.4 million in Q4 2023, from $43.9 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $52.5 million in Q3 2022 to a low of $25.7 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | QuidelOrtho | 1.13 Bn | 990.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 48.40 Mn |
| Oct 1, 2023 | 43.90 Mn |
| Jul 2, 2023 | 45.10 Mn |
| Apr 2, 2023 | 42.80 Mn |
| Jan 1, 2023 | 52.10 Mn |
| Oct 2, 2022 | 51.80 Mn |
| Jul 3, 2022 | 52.50 Mn |
| Jan 2, 2022 | 25.70 Mn |